Zylox-Tonbridge Medical Technology acquires optimed
Zylox-Tonbridge Medical Technology agreed to acquire optimed. Reported deal value: €41.2M. Status: Pending. Sector: Medical Technology. Target headquarters context: Ettlingen, Baden-Wuerttemberg, Germany.
This page summarizes publicly available information about the transaction as of 2026-03-18. Figures and status may change as filings and press coverage update.
Zylox - Tonbridge Medical to Acquire Remaining Interest in German Vascular Device Maker Optimed — Details on Discloseable Transaction and Strategic Global Expansion 1 Posted on March 18 , 2026 at 9:34 am 26 Share on Facebook Share on Twitter Zylox - Tonbridge Medical Technology Co., Ltd
Deal timeline
This transaction is classified in Medical Technology with a reported deal value of €41.2M. Figures and status may change as sources update.